Associate Professor at Emory University. Director of Center for Childhood Infections and Vaccines; Virologist; Immunologist; Emerging Viruses
Emory University
Joined June 2014
- Tweets461
- Following2K
- Followers3.4K
- Likes412
Mehul Suthar retweeted
Trump's proposal is ILLEGAL & amounts to an indiscriminate funding cut for research centers of all sizes, NOT just Ivies. It will mean shuttering labs across the country, layoffs in red & blue states, & derailing lifesaving research on everything from cancer to opioid addiction.
Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above what many major foundations allow and much lower than the 60%+ that some institutions charge the government today. This change will save more than $4B a year effective immediately.
Mehul Suthar retweeted
Yesterday, January 27th, we had our first seminar of the semester. Our special guest was Dr. Shilu Malakar, a post-doctoral fellow of the @SutharLab. Join us every Monday from 1 pm -2 pm for the CCIV Weekly Seminar Series. nam11.safelinks.protection.o…
Mehul Suthar retweeted
So excited to join the Division of Immunobiology at Cincinnati Children's Hospital MC in March 2025. My lab will study how RNA biology regulates and is regulated by infection and immunity.
We'll be hiring at all levels in 2025 - stay tuned!
gokhalelab.com/
Intriguing study in Science from @nandangokhale and colleagues @UW re how cellular RNAs regulate an antiviral immune signaling complex dubbed MAVS. Excited that Dr. Gokhale will be joining the faculty @CincyChildrens in March. @ThePasareLab #immunology science.org/doi/10.1126/scie…
Mehul Suthar retweeted
This is the beginning of the end of our long list of manuscripts in preparation! Single-cell virology: On-chip, quantitative characterization of the dynamics of virus spread from one single cell to another biorxiv.org/content/10.1101/…
Mehul Suthar retweeted
New report of a nasal vaccine booster provides strong, durable #SARSCoV2 cross-variant protection—preventing infection— compared with shots in non-human primates
nature.com/articles/s41590-0…
@NatImmunol
Mehul Suthar retweeted
Two new papers report the specificity & differentiation dynamics of human LN TFH cells after flu or COVID vaccines. The flu paper is a collab. between my lab (@sschattgen ) & Ali Ellebedy, while the COVID was led by Ali, Philip Mudd, and @theHumanBorch-a 🧵nature.com/articles/s41590-0…
Mehul Suthar retweeted
Today @WHO launched a new network for coronaviruses, CoViNet, to facilitate and coordinate global expertise and capacities for early and accurate detection, monitoring and assessment of #SARSCoV2, #MERS-CoV and novel CoVs of public health importance.
who.int/news/item/27-03-2024…
Mehul Suthar retweeted
Here's one of the reasons that could explain why the monovalent XBB.1.5 booster works so well
biorxiv.org/content/10.1101/… @SutharLab
Mehul Suthar retweeted
Having a safe and effective vaccine for RSV has been a career-long dream. Excess mortality in frail elderly is a problem. Hospitalization and lung damage in young infants also problematic. Maternal vaccine to protect babies through 1st 6 months of life also in phase 3 testing.
Received an email from Rino Rappuoli this morning informing me, @BarneyGrahamMD and Peter Kwong of the positive phase III data for the RSV prefusion F vaccine results in older adults. It's been almost 10 years since we designed the first prefusion RSV F antigen, DS-Cav1. Amazing!
Mehul Suthar retweeted
Celebrating the new boss, @SesmaLab ! With @VivianaSimonLab @jeanklim @mschotsaert and many others from our department. Cheers to Ana and to a bright future for Mount Sinai Microbiology!
Thanks to Daniel Caughey for organizing this!
Mehul Suthar retweeted
Very excited to see that our recent paper in Nature Materials was highlighted in a news and views article this month! Take a look! nature.com/articles/s41563-0… @CoulterBME @ugavetmed @NatureMaterials @DARPA @GT_CHEM
Mehul Suthar retweeted
"Virology under the Microscope—a Call for Rational Discourse": new open access Commentary co-published in @asmicrobiology journals #jvirology, @msphereJ, and @mbiojournal doi.org/10.1128/JVI.00089-23
Mehul Suthar retweeted
I am very excited to share that @ljiresearch, my scientific family, is supporting my scientific career growth. I am grateful to my team and all the scientists that helped me reach this goal! A special thanks to my fantastic mentor @Settelab #Grifonilab
lji.org/labs/grifoni-lab/
Mehul Suthar retweeted
Putting love into the world comes back 3xs as much… thankful for everyone who has reached out and prayed. This will make me stronger on the road to recovery, keep praying for me! 🫶🏾3️⃣
Mehul Suthar retweeted
The love is felt, & extremely real. No matter race or religion everybody coming together in prayer! 🙏❤️
Mehul Suthar retweeted
Excited to share our latest study looking at #CovidVaccine booster in #NHL and #CLL patients. #SeroNet. @WinshipAtEmory @rafiahmed_lab @JeanKoffMD @PamAllenMD1 @jonathonbcohen @SutharLab @MadhavDhodapkar
aacrjournals.org/cancerresco…
Mehul Suthar retweeted
Everyone should have Hamlin in their prayers no matter what team they support or if they even follow football🙏🙏
Mehul Suthar retweeted
Dr. Fauci was eligible for his COVID booster shot so Stephen took him next door to the pharmacy to get vaccinated — and they had quite the journey.
#Colbert
Mehul Suthar retweeted
Dr. Stephanie Foster, @rkdrummer216, will be presenting during tonight’s ASV poster session on SARS-CoV-2 infection-induced immunity from 8:30-10:00 pm. Learn more about her research in the @SutharLab at #ASV2022. #MeetCEIRR
